Bavarian Nordic AS operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Bavarian Nordic AS with three other
miscellaneous service companies in Europe:
Pharma Mar SA
sales of 179.36 million Euro [US$221.98 million]
of which 60%
was Biotech Sector),
(155.92 million Euro [US$192.97 million]
of which 76%
was R&D), and
Bachem Holding AG
based in Switzerland
(261.61 million Swiss Francs [US$269.98 million]
of which 88%
was Active Pharmaceutical Ingredients).
Bavarian Nordic AS reported sales of 1.37 billion Danish Kroner (US$227.64 million)
December of 2017.
increase of 36.1%
versus 2016, when the company's sales were 1.01 billion Danish Kroner.